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What is already known about this topic? 
• The use of outcome assessment tools are important to measure quality and effectiveness of care. 
• The population of children requiring paediatric palliative care services is diverse. 
• There are no outcome assessment tools validated specifically for use within paediatric palliative care   
What this paper adds? 
• This is the first review to systematically identify existing health-related quality of life outcome measures for use in paediatric palliative care. 
• The paper finds that there is currently no ‘ideal’ outcome assessment tool for use in paediatric palliative care.  
Implications for practice, theory or policy 
• A selection of both outcome and experience measures for use within this population may be useful. 
• In order to measure what is important to the individual child and family it may be better to allow them to choose their own goals for care and treament.  
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ABSTRACT 
Background:  The number of children worldwide requiring palliative care services is 
increasing due to advances in medical care and technology.  The use of outcome 
measures is important to improve the quality and effectiveness of care. 
Aim: To systematically identify health related quality of life (HRQOL) outcome 
measures that could be used in paediatric palliative care (PPC) and examine their 
feasibility of use and psychometric properties.  
Design: A systematic literature review and analysis of psychometric properties. 
Data sources: PsychInfo, Medline and EMBASE were searched from 1 January 1990 
to 10 December 2014.  Hand searches of the reference list of included studies and 
relevant reviews were also performed. 
Results:  From 3460 articles, 125 papers were selected for full text assessment.  41 
articles met the eligibility criteria and examined the psychometric properties of 22 
HRQOL measures. Evidence was limited as at least half of the information on 
psychometric properties per instrument was missing. Measurement error was not 
analysed in any of the included articles and responsiveness was only analysed in one 
study. The methodological quality of included studies varied greatly. 
Conclusion:  There is currently no ‘ideal’ outcome assessment measure for use in 
PPC.  The domains of generic HRQOL measures are not relevant to children 
receiving palliative care and some domains within disease-specific measures are only 
relevant for that specific population.  Potential solutions include adapting an existing 
measure or developing more individualized patient centred outcome assessment 
measures. Either way, it is important to continue work on outcome measurement in 
this field.  
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Background 
 
Palliative care for children begins at diagnosis and encompasses children with a 
variey of life limiting and life threatening conditions. Life limiting conditions are 
diseases where there is no reasonable hope of cure and that will ultimately be fatal1.  
Life threatening conditions are those where curative treatment may be possible but 
can fail, for example cancer. Worldwide, more children are living longer with such 
conditions due to advances in medical care. Paediatric palliative care (PPC) is about 
helping children and their families deal with their medical condition, while enabling 
them to live life to the fullest.2  Palliative care for children and young people (CYP) is 
an active and total approach to care, and begins at the point of diagnosis, throughout 
the child’s life, death and beyond.3 The scope of paediatric palliative care is broad and 
PPC services care for children and young people with a wide variety of illnesses, 
many of which are extremely rare.3,4  Children can be receiving care from these 
services for many years and therefore it is imperative to ensure that they are supported 
to live life to their fullest potential. 
Health related quality of life (HRQOL) has been described as a subjective, 
multidimensional and dynamic construct that comprises physical, psychological and 
social functioning.5  HRQOL measurement instruments must consist of physical, 
social and mental health dimensions as delineated by the World Health Organisation 
(WHO).6  Given that one of the goals of PPC is to improve HRQOL, service 
providers, researchers, fundraisers and policy makers will want to measure HRQOL 
and determine the effectiveness of services in achieving this.   
There are no paediatric HRQOL measures that have been successfully validated for 
use within PPC.  One study did attempt to validate the well-used Pediatric Quality of 
Life 4.0 measure in children with a variety of life-limiting conditions.  However, the 
study found that the instrument did not have valid psychometric properties for use 
within this population.7 Therefore, within PPC two possibilities exist; devising a 
completely new HRQOL instrument, or revising and validating an existing one.  A 
review of existing HRQOL measures is essential prior to deciding which course of 
action to take.  
The aim of this systematic literature review is to examine the measurement properties 
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of existing HRQOL instruments for use in those up to 18 years old.  It will also assess 
the feasibility of the measures being used in the CYP palliative care population in 
terms of completion time, response options, recall period, format, domains and 
whether the measure is parent, professional or self-completed.   
 
Methods 
This systematic literature review was performed in accordance with Preferred 
Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines.8 
Identification of Studies 
PsychInfo, Medline and Embase were searched from 1 January 1990 to 10 December 
2014. Experts in the field of were asked to suggest any further measures.  The search 
terms used included keywords such as child, adolescent and teenager in combination 
with terms used to find studies on measurement properties of health related quality of 
life measures.9.10 Language restriction to the English language was applied due to 
practical constraints within the research team. Reference lists of included articles were 
also searched for further publications.  Box 1 shows the search strategy used. 
Box 1. Search strategy 
1. patient reported outcomes.ti,ab.(6383) 2. quality of life.ti.ab.(266914) 3. health status.ti,ab.(175146) 4. global health.ti.ab.(53851) 5. health related quality of life.ti.ab.(53363) 6. outcome measurement.ti.ab.(26871) 7.  1 or 2 or 3 or 4 or 5 or 6(491494) 8. classical test theory.ti.ab.(1460) 9. validity.ti.ab(205095) 10. reliability.ti.ab.(162542) 11. content validity.ti.ab.(16710) 12. confirmatory factor analysis.ti.ab.(17892) 13. exploratory factor analysis.ti.ab.(13537) 14. internal consistency.ti.ab.(39236) 15. test-retest.ti.ab.(30481) 16. psychometr*.ti.ab.(66358) 17. known group.ti.ab.(108113)   
18. Rasch.ti.ab.(5442) 19. DIF.ti.ab.(2784) 20. 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 (998874) 21. child*.ti.ab.(1286933) 22. neonat*.ti.ab.(185516) 23. adolescent*.ti.ab.(308550) 24. pediatric*.ti.ab.(213646) 25. paediatric*.ti.ab.(48497) 26. 23 or 24 or 25 or 26 or 27 (1715918) 27. 7 and 22 and 28 (7138) 28. 29 limited to Human and English Language and Age Groups All Child Age 0-18 years (4849) 29. Duplicates removed 1398 30. Total 3451.  
 
Inclusion/Exclusion Criteria 
A study was included if it met the following inclusion criteria: 
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• Full text article 
• Written in the English language 
• Examining one or more measurement properties of an instrument that 
measured physical, mental and social aspects of HRQOL as delineated by 
WHO6 
• The study population were under 18 years old 
• The measure was generic or disease specific 
• Disease specific instruments had to assess HRQOL in an illness considered to 
be life-limiting or life-threatening3,4 
• Studies of generic measures were included only if some or all of the 
population in the study had a life-limiting illness 
• Included measures could be completed by the CYP, parent or clinician 
 
 
Study Selection 
The results of the search were thoroughly checked and full manuscripts of all studies 
whose title/abstract seemed to meet the selection criteria were retrieved.  Independent 
reviewers (LC and GL) examined these full text articles and made the final decision 
as to whether they were included. 
 
Data extraction 
The methodological quality of included studies was rated using the COnsensus based 
Standards for the selection of health Measurement INstruments (COSMIN) 
checklist.11  This checklist contains nine boxes, each dealing with one measurement 
property.  There are 5-18 items per box (98 items in total) that can be used to assess 
whether a study on a specific measurement property meets the standard for good 
methodological quality.  The checklist evaluates the following measurement 
properties: internal consistency, reliability, measurement error, content validity, 
construct validity (structural validity, hypothesis testing, cross-cultural validity), 
criterion validity and responsiveness.  There are three additional boxes: one to assess 
the methodological quality of studies on interpretability, one to assess the 
generalisability of results and one that includes extra methodological standards for 
studies that use item-response theory (12 boxes in total).  Each item is scored on a 4-
 6 
point rating scale (poor, fair, good, excellent).12  An overall score for the 
methodological quality of a study is determined for each measurement property 
separately, by taking the lowest rating of any item in a box (worst score counts).11   
Box 2 gives definitions of these measurement properties. 
 
Box 2. Definitions of measurement properties 
Reliability 
 This term is used twice – as a term for the domain and also as the term for the measurement property.13,14 Defined as the degree to which measurement is free from measurement error. Includes internal consistency, reliability (test-retest, inter-rater, intra-rater) and measurement error.12, 13, 15  
Validity 
 The degree to which a tool measures the construct it claims to measure. Includes content validity, criterion validity and construct validity.13,15  
Responsiveness 
 The ability of an instrument to detect change over time in the construct being measured.16  
Interpretability 
 The degree to which qualitative meaning can be assigned to the quantitative scores or change in scores of an instrument. This is an important property of an instrument but not a measurement property.13 
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Synthesis of results 
To summarise the evidence of measurement properties of each included instrument, 
the results were combined.  The number and methodological quality of the studies 
were taken in to account, along with the consistency of results. A method similar to 
that proposed by the Cochrane Back Review Group was used (Table 1).17 
 
The overall rating of each measurement property is ‘positive’, ‘negative’ or 
‘indeterminate’, accompanied by levels of evidence. These criteria were originally 
meant for systematic reviews of clinical trials but have been used in reviews on 
measurement properties.12  To assess whether results of measurement properties were 
positive, negative, or indeterminate, criteria based on Terwee et al were used (Table 
2).18 
 
This assessment of measurement properties was then looked at alongside the 
feasibility of each measure being used in PPC in terms of completion time, response 
options, recall period, format and domains. 
 
Research ethics committee/IRB approvals were not required as this was a systematic 
review of pre-existing evidence 
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Results 
Paper selection 
Three thousand four hundred and fifty one articles were found using the search 
strategy and a further nine were found via reference searching.  One hundred and 
twenty five of these were selected for full text review based on title and abstract.  
Forty one were selected to be included in the review. Figure 1 shows a flow chart of 
the article selection process and table 3 shows the general characteristics of included 
studies. 
 
Figure 1. PRISMA flow chart 
 
  
From Moher et al.8 
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Summary of results 
The 41 articles included evaluated 22 health related quality of life measures for use 
with children aged 0-18 years old. Two papers discussed the results from the same 
study so were only analysed once.19,20  All included measures were originally 
developed to be completed in paper format.  Five of the included measures were 
generic and 17 were disease specific.  Of the disease specific measures, three are for 
use with children with cardiac disease, three for cerebral palsy, six for cancer, one for 
brain tumours, three for epilepsy and one for neuromuscular disease. Four measures 
are child completed, four parent completed, thirteen have both parent and child forms 
and one measure had both child and clinician forms.   Completion time ranged from 
two to 25 minutes, with the number of items ranging from six to 87.  Recall time 
ranged from the current moment to one month. Table 3 shows a summary of the 
included studies, where data is missing it is because it was not available. 
 
None of the studies included analysed measurement error or cross-cultural validity.  
One study reported on responsiveness and one on criterion validity31.  The COSMIN 
panel define criterion validity as 'the degree to which the scores of an instrument are 
an adequate reflection of a gold standard'.16   As outcome measures focus on 
perceptions that may by subjective, they usually lack a gold standard.  The only 
exception to this would be if a shorter version of a measure was developed from an 
already validated longer one, where the longer version could be considered to be the 
gold standard. Therefore, the results of this analysis of criterion validity have not been 
included here. 
 
The methodological quality of included studies is shown in Table 4 and ranged from 
poor to excellent.   Table 5 shows the synthesis of results per outcome measure with 
levels of evidence of quality.  This ranged from strong to unknown. 
 
Internal consistency was tested in 34 of the included studies.  However 40% of these 
lacked a check of the uni-dimensionality of the scale, leading to a score of poor for 
methodological quality. 59   
Test-retest reliability testing was carried out in 14 of the studies. 38% of studies had a 
sample size of at least 100 which is needed for an excellent quality score11. Only one 
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study described how missing items were handled.  If not handled appropriately this 
could lead to over or under estimation of reliability. 
Content validity testing was carried out in 13 of the included studies.  The main flaws 
in the methodology of content validity testing were inclusion of only small numbers 
in focus groups, pilot studies and cognitive testing, and not involving children, parents 
and professionals in the process. Ideally, all should be included to make sure the items 
are relevant and ensure no important items are missing. 
 
Structural validity can be assessed by factor analysis or item response theory (IRT) 
tests for dimensionality.12 Structural validity was assessed in 14 of the studies and 
generally there was appropriate use of confirmatory or exploratory factor analysis.  In 
order to carry out structural validity testing a sample size of 5-7 times the number of 
items (and greater than 100) is recommended.11 This was achieved in 93% of the 
studies. Lack of description of missing items and how they were handled let down 
64% of the studies. 
 
Only one study analysed responsiveness.58 No correlations between change scores 
were calculated in the included study, a paired t-test was carried out instead thus the 
methodology for this was scored as poor. Sample size was also inadequate and there 
was no description of how missing items were handled.
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Discussion 
Main findings  
To the authors’ knowledge, this is the first systematic review of outcome measures 
that could potentially be used in paediatric palliative care.  The aim of this review was 
to  examine the feasibility of use of measures, as well as the methodological quality of 
analysis of measurement properties of included studies. The review identified 22 
measures, five generic and 17 disease specific, that could potentially be useful.  The 
disease specific measures included those for use in children with cardiac 
disease,25,38,39,40,51 cerebral palsy,26,27,52, cancer,34,35,36,37,41,50,58 brain tumours,49 
epilepsy31,32,56 and neuromuscular disease.53,54,55  All measures were initially 
developed in the English language.  None of the measures were developed for use in 
CYPs receiving palliative care.  All were developed to be completed in paper format, 
predominantly by the CYP and/or their parent. 
The PedsQLTM Generic Core Scale was the most widely analysed in terms of its 
measurement properties.  It is unique because it contains a generic core scale and 
various disease specific modules that can be administered alongside the core scale.   
Quality of assessment of measurement properties 
None of the studies on measurement properties in this review achieved a score of fair 
methodological quality or higher in all characteristics.  Most of the studies show 
positive results (except parent test-retest reliability in two studies and hypothesis 
testing in one, see table 5). Evidence is mainly limited and at least half the 
information on measurement properties per questionnaire is missing. The 
methodological quality of the included studies varied greatly and therefore results 
should be treated cautiously.   
 
Internal consistency, reliability, content validity and hypothesis testing were widely 
assessed in the papers.  Only one study analysed responsiveness (Watson et al).58 It is 
imperative that any measure used to assess HRQOL is responsive to change, 
particularly in paediatric palliative care, where a child’s condition can change 
frequently and sometimes rapidly. Measurement error was not tested for in any of the 
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included studies.  With the same data, both reliability and measurement error can be 
calculated.12 14 of the 22 included studies assessed reliability, thereby measurement 
error could easily have been reported on. 
 
Feasibility of Use of Included Measures 
In adult palliative care there are concerns regarding the use and relevance of outcome 
measures.60  These concerns include the method of administration and whether the 
patient, carer or professional completes the measure.60 These concerns are probably 
just as applicable to PPC. Many children requiring palliative care services are non-
verbal or too unwell to self-complete the tools and thereby rely on the reports of their 
carers and/or professionals.  The method of administration of a measure is also 
important.  Different modes of administration may be appropriate depending on the 
type and stage of a CYPs illness.  The PedsQLTM is the only measure included in this 
review that has been validated across different modes of administration.48  Multi-
group confirmatory factor analysis was performed showing strong factorial invariance 
across three modes of administration groups (mail, in-person and telephone survey).  
With widespread mobile technology now available, new ways of collecting data, such 
as online or via an app should be considered as these may be more acceptable to 
CYPs and their carers, as well as being easier to access. 
 
Within PPC, as in adult palliative care, there is a debate as to who should complete 
outcome measures.  Most children with life limiting and life threatening illnesses are 
cared for at home by their parents, so a clinician completed measure is not always 
ideal. HRQOL is generally understood as a latent, not directly observable construct, 
and contains the perceptions and evaluation of one’s life from the subjective view of 
the individual, as well as the individual’s subjective well-being and affective mood.61  
Wherever possible, the child’s self-report of HRQOL should be sought. Within this 
population some children will be too young or too unwell to complete a measure and 
a parent/proxy completed measure will need to be used. Nineteen of the 22 measures 
included in this review contain parent reports.  Of those studies that looked at 
correlation between child and parent scores three found moderate correlation between 
parent and child scores.37,38,49  One study showed poor correlation in the 
psychological and emotional subscales.52  These results support those of previous 
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studies that show a higher correlation for observable constructs, such as physical 
aspects, and a lower correlation for non-observable constructs such as emotional 
problems between parents and children.62 
Recall period in the included studies ranged from the current moment to 1 month. 
Research has shown that children as young as 8 years can use a 4 week recall period 
with accuracy.63  However, HRQOL measures with shorter recall periods are likely to 
elicit more accurate responses.64  Most of the disease specific measures had shorter 
recall periods, which is more appropriate as there can be variation in symptoms over a 
longer period in many cases.  Children with palliative care needs often have 
frequently changing symptoms which can affect their HRQOL so a measure with a 
shorter recall period may be more appropriate. 
 
There were a variety of response options used in the included measures.   The most 
common method was a Likert scale and response options ranged from 3-9 points.  It 
has been recommended that fewer responses should be employed for younger children 
as they tend to choose responses at the extremes.63  There is also little evidence 
showing that young children can effectively respond to Likert scales.64 The 
completion time (when reported) for measures was between 2 and 25 minutes.  
Shorter measures are preferable in PPC as children will fatigue easily.  Shorter parent 
completed measures are also preferable as parents will already have the burden of 
caring for their sick child. 
 
HRQOL instruments may be either generic or disease specific.7 Generic measures are 
useful for comparing general quality of life across different populations.  These 
measures are used with healthy children so are more likely to have been validated 
based on large samples but may lack sensitivity in sick children and young people. 
Disease specific quality of life instruments, on the other hand, are used to compare 
quality of life within a given condition. Disease specific measures are assumed to be 
more sensitive to the implications of different illnesses and may be more appropriate 
for evaluating interventions or different treatments within CYPs with the same 
illness.62 The drawback of this is that it is not possible to compare HRQOL across 
groups of CYPs with different illnesses, which is essential for a discipline as wide and 
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varied as PPC.  The measures included in this study contain varying numbers of 
domains but all covered the constructs of HRQOL (physical, emotional and social). 
Some of the domains included in the generic HRQOL measures may not be relevant 
for the PPC population.  For example, domains such as school environment may be 
irrelevant for a child near the end of life. One of the included studies aimed to validate 
the PedsQLTM in children with life-limiting illnesses.7 Confirmatory factor analysis 
did not support the construct validity of the PedsQLTM in this group of children, 
implying that the hypothesized HRQOL structures between children with life-limiting 
illnesses and other populations may be different. Most of the generic measures 
included in this review do not capture the impact of life-limiting illness on daily 
functioning and well-being.   
 
Implications for research 
As discussed above, it is questionable whether any of the include generic measure, 
such as the PedsQLTM and Child Health Questionnaire would be valid in the PPC 
population without adaptation, due to concerns regarding construct validity. The 
Memorial Symptom Assessment Scales for children could potentially be useful in 
PPC.34,35 Although they capture many of the domains of PCC, they would need 
testing for validity and reliability in the population.  It is unlikely that without 
adaptation, they would be useful in a non-cancer population as there is a question 
about hair-loss, which is unique to this group of children. The methodological quality 
of studies on the MSAS was fair throughout.  Other disease specific measures 
included in this review may be useful in PPC.  For example, the PedsQLTM 
Neuromuscular module was designed for use in children with spinal muscular atrophy 
and muscular dystrophy which are both life-limiting conditions.53,54,57  However, 
within the three studies included in this review, the majority of assessment of its 
psychometric properties was scored as fair or poor. It is unlikely that any of the 
included measures would have acceptable measurement properties in the entire range 
of children receiving PPC services, as the population is so diverse.   
 
None of the measures included in this review meet all the requirements for use in the 
PPC population.  The generic measures do not capture the full impact of living with a 
life-limiting illness and often have recall periods that could be considered too long in 
a child whose condition may be changing frequently. The disease specific measures 
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contain domains that are only relevant to CYPs with specific illnesses so could not be 
used to compare children with different conditions.  One potential solution to this is to 
revise an existing instrument. An alternative is to develop a completely new measure. 
It is questionable whether by using either method it will be possible to develop a 
HRQOL outcome measure for a population as diverse as PPC. Children have many 
different types of illness, some of which are extremely rare and each illness comes 
with its own set of physical, psychological and emotional needs.  All items in a 
measure may not be equally useful for children with different life-limiting conditions.  
Findings from other studies have suggested that static models (all items are 
administered to all subjects) will increase measurement error and decrease precision.7  
The use of item response theory (IRT) along with computerized adaptive testing 
(CAT) may better assess HRQOL for this population.7  Alternatively, using 
individualized measurement tools rather than standardized ones may be a solution.7  
The Schedule for the Evaluation of Individual Quality of Life (SEIQoL) has been 
shown to be valid and reliable in a population of terminally ill adult cancer patients.65   
 
Two relatively new concepts in healthcare, patients reported experience measures 
(PREMs) and patient centered outcome measures (PCOMS) may also be beneficial to 
CYPs and their families receiving palliative care services, but more research in this 
area is required.  PCOMs involve putting patients and their families/carers at the heart 
of deciding which goals are most valuable for an individual, rather than clinicians 
deciding what is best.66  PREMs measure patient experience with the goal of 
improving services.  It is desirable to combine measures of experience with measures 
of outcome to obtain a rounded view of the quality of care.67   
 
Strengths and Limitations  
This review has several strengths.  First of all, this is the first review the authors are 
aware of which examines the measurement properties and feasibility of using already 
developed outcome measures in the paediatric palliative care population.  The review 
was comprehensive, the search strategy found more than 3000 articles for potential 
inclusion and over 40 papers were systematically appraised and compared. 
 
This review also has several limitations.  Firstly, it is never possible to be sure that all 
relevant studies have been identified.  The COSMIN check list is based on expert 
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group opinion. The inter-rater agreement of the COSMIN checklist is reported 
adequate. The inter-rater reliability for many COSMIN items is poor, which has been 
suggested to be due to interpretation of checklist items.68 Selected articles were 
restricted to English language.  Finally, it was sometimes not clear if certain criteria 
on the COSMIN checklist were not performed or not reported on.  Therefore it was 
not possible to distinguish between poor reporting and poor quality.   
 
 
 
 
Conclusion 
Although there is no ‘ideal’ HRQOL measure for use in paediatric palliative care at 
the moment it is important to continue developing and researching measures in this 
area.   
Outcome measurement in PPC is rarely carried out and as of yet there are no specific 
HRQOL measures for use in this population. In light of new developments in the field 
of PREMS and PCOMs it may be desirable to develop a combination of measures that 
are able to measure outcomes that are important to the individual child and family, as 
well as measuring their satisfaction of the experience of the services that deliver care. 
The purpose of measuring quality of life and outcomes in CYPs receiving PPC is 
potentially fourfold; to improve clinical care, to audit and evaluate services, for 
research purposes and to inform commissioners and secure funding.60  
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Table 1.  Levels of Evidence for Overall Quality of Measurement Property 
Level Rating Criteria 
Strong +++ or --- Consistent findings in multiple 
studies of good methodological 
quality OR in one study of 
excellent methodological quality 
Moderate ++ or -- Consistent findings in multiple 
studies of fair methodological 
quality OR in one study of good 
methodological quality 
Limited + or - One study of fair 
methodological quality 
Conflicting ± Conflicting findings 
Unknown ? Only studies of poor 
methodological quality 
+ positive results     - negative results 
Source: Tulder et al 17 
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Table 2.  Quality Criteria for Measurement Properties 
Property Rating Quality Criteria 
Reliability 
Internal Consistency 
 
 
   Measurement Error 
 
 
   Reliability 
 
      + 
      ? 
      - 
      + 
      ? 
      - 
      + 
      ? 
      - 
 
(Sub)scale unidimensional AND Cronbach’s alpha(s) ≥0.70 
Dimensionality not known OR Cronbach’s alpha not determined 
(Sub)scale not unidimensional OR Cronbach’s alpha<0.7 
MIC>SDC OR MIC outside the LOA 
MIC not defined 
MIC≤SDC OR MIC equals or inside LOA 
ICC/weighted kappa≥0.70 OR Pearson’s r≥0.80 
Neither ICC/weighted kappa, nor Pearson’s r determined 
ICC/weighted kappa<0.70 OR Pearson’s r <0.80 
Validity 
   Content validity 
 
 
 
 
  Construct validity 
      Structural validity 
 
 
Hypothesis testing 
 
      + 
 
      ? 
      - 
 
 
      + 
      ? 
      - 
      + 
 
 
 
      ? 
      - 
 
The target population considers all items in a questionnaire to be 
relevant AND considers the questionnaire to be complete 
No target population involvement 
The target population considers items in a questionnaire to be irrelevant 
OR considers the questionnaire to be incomplete 
 
Factors should explain at least 50% of the variance 
Explained variance not mentioned 
Factors explain<50% of the variance 
(Correlation with an instrument measuring the same construct ≥0.50 OR 
at least 75% of the results are in accordance with the hypotheses) AND 
correlation with related constructs is higher than with unrelated 
constructs 
Solely correlations determined with unrelated constructs 
Correlation with an instrument measuring the same construct <0.50 OR 
<75% of the results are in accordance with the hypotheses OR 
correlation with related constructs is lower than with unrelated 
constructs 
Responsiveness 
   Responsiveness 
 
      + 
 
 
 
      ? 
      - 
 
(Correlation with an instrument measuring the same construct ≥0.50 OR 
at least 75% of the results are in accordance with the hypotheses OR 
AUC ≥0.70) AND correlation with related constructs is higher than 
with unrelated constructs 
Solely correlations determined with unrelated constructs 
Correlation with an instrument measuring the same construct <0.50 OR 
<75% of the results are in accordance with the hypotheses OR AUC 
<0.70 OR correlation with related constructs is lower than with 
unrelated constructs 
MIC = minimal important change; SDC = smallest detectable change; LOA = limits of agreement; ICC 
= intraclass correlation coefficient; AUC = area under the curve 
 
+ positive rating; ? indeterminate; - negative rating.     Source Terwee et al18 
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Table 3. Summary of included studies 
Measure Study Report  
  
Age (y) No. of Domains No. of 
items 
Recall 
period 
Completion 
time  (mins) 
Study 
Population 
Generic/Disease 
Specific 
Country of 
origin 
Child Health 
Questionnaire – 
Parent Form 50 
Drotar21 
Ferro22 
McCullough23 
Wake24 
 
Parent 5-18 11 (physical functioning, 
role/social -physical, 
general health 
perceptions, bodily 
pain/discomfort, parental 
impact time, role/social-
emotional/behavioural, 
self-esteem, mental 
health, general behavior, 
family activities, family 
cohesion, change in 
health) 
50 4 weeks Not 
reported 
Chronic illness 
Epilepsy 
Cerebral palsy 
Cerebral palsy 
Generic USA 
ConQol Macran25 Self 
 
 
8-11 
 
12-16 
3 (symptoms, activities, 
relationships) 
 
4 (symptoms, activities, 
relationships, control and 
coping) 
29 
 
35 
1 week Not 
reported 
Congenital 
heart disease 
Disease specific -
congenital heart 
disease 
UK 
CP-QOL Waters26 Self 
 
 
 
 
 
Parent 
9-12 
 
 
 
 
 
4-12 
5 (social well-being and 
acceptance, functioning, 
participation and physical 
health, emotional well-
being, pain and impact of 
disability) 
7 (social well-being and 
acceptance, functioning, 
participation and physical 
health, emotional well-
being, access to services, 
pain and impact of 
disability, family health) 
52 
 
 
 
 
 
66 
 
 
 
15-25  Cerebral palsy Disease specific – 
cerebral palsy 
Australia 
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Measure Study Report  
  
Age (y) No. of Domains No. of 
items 
Recall 
period 
Completion 
time  (mins) 
Study 
Population 
Generic/Disease 
Specific 
Country of 
origin 
CP-QOL Teen Davis27 Self 
 
 
 
Parent 
 
 
 
 
13-18 7 (well-being and 
participation, 
communication and 
physical health, school 
well-being, social well-
being, access to services, 
family health, feelings 
about functioning) 
70 
 
 
 
87 
 Not 
reported 
Cerebral palsy Disease specific-
cerebral palsy 
Australia 
DISABKIDS Petersen28 
Ravens-
Sieberer19/Schmid
t20 (d) 
Simeoni29 
Self  
 
Parent 
4-16 6 (independence, 
emotion, social exclusion, 
social inclusion, physical, 
medication) 
 
37  Not 
reported 
Chronic illness 
 
 
Condition generic Multiple – 
Europe 
DISABKIDS Smiley 
(TAKE 6 scale) 
Chaplin30 Assisted 
report 
 
Parent 
 
4-7 1 (HRQOL) 6  2  Chronic illness Condition generic Multiple-
Europe 
Glasgow Epilepsy 
Outcome Scale for 
Young Persons 
(GEOSYP) 
Townshend31 Self 10-18 9 (peer acceptance, 
school/work, 
development of 
autonomy, future focus, 
epilepsy as part of me, 
medication issues, 
seizures, knowledge 
about epilepsy, sense of 
uncertainty) 
 
50 4 weeks Not 
reported 
Epilepsy Disease specific - 
epilepsy 
UK 
Health related 
quality of life in 
children with 
epilepsy 
Ronen32 Self 
 
 
Parent 
8-15 
years 
5 (interpersonal/social, 
future worries, present 
worries, 
intrapersonal/emotional, 
secrecy) 
25 Current 
moment 
Not 
reported 
Epilepsy Disease specific - 
epilepsy 
Canada 
 
 27 
Measure Study Report  
  
Age (y) No. of Domains No. of 
items 
Recall 
period 
Completion 
time  (mins) 
Study 
Population 
Generic/Disease 
Specific 
Country of 
origin 
KIDSCREEN-52 Erhart33 Self 
 
Parent 
8-18 
 
10 (physical wellbeing, 
psychological wellbeing, 
moods and emotions, 
self-perception, 
autonomy, parent 
relation and home life, 
social support and peers, 
school environment, 
social acceptance 
(bullying), financial 
resources) 
 
52 
 
 
1 week 15-20  Mixed 
 
 
Generic 
 
 
Multiple – 
Europe 
wide 
Memorial 
Symptom 
Assessment Scale 
(MSAS) 7-12 
 
MSAS 10-18 
Collins34 
 
 
 
 
Collins35 
Self 
 
 
 
 
Self 
7-12 
 
 
 
 
10-18 
1 (symptom experience) 
 
 
 
 
3 (physical, psychological, 
global distress) 
8 
 
 
 
 
30 
2 days 
 
 
 
 
1 week 
6  
 
 
 
 
11 
Cancer 
 
 
 
 
Cancer 
Disease specific - 
cancer  
 
 
Disease specific -
cancer 
UK 
Australia 
 
 
 
USA 
Pediatric Cancer 
Quality of Life 
Inventory (PCQL-
32) 
Varni36 
Seid37 
Self/par
ent 
 
 
8-18 
 
 
5 (disease/treatment,  
physical functioning, 
psychological functioning, 
social functioning, 
cognitive functioning) 
32 
 
 
1 month Not 
reported 
Cancer Disease specific- 
cancer 
USA 
Pediatric Cardiac 
Quality of Life 
Inventory 
Marino38 
Marino39 
Wray40 
 
Self 
 
 
Parent 
 
Self 
 
Parent 
8-12 
 
 
8-12 
 
13-18 
 
13-18 
2 (disease impact, 
psychosocial impact) 
 
2 (as above) 
 
2    “ 
 
2    “ 
23 
 
 
23 
 
29 
 
29 
Current 
moment 
10  Cardiac disease Disease specific - 
cardiac disease  
USA 
 
UK testing 
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Measure Study Report Age (y) No. of Domains No. of 
items 
Recall 
period 
Completion 
time  (mins) 
Study 
Population 
Generic/Disease 
Specific 
Country 
of origin 
Pediatric Oncology 
Quality of Life 
Scale 
Goodwin41 Parent 0-18 3 (physical function and 
role restriction, 
emotional distress, 
reaction to current 
treatment) 
21 2 weeks Not 
reported 
Cancer Disease specific - 
cancer 
USA 
PedsQLTM 4.0 
Generic Core 
Scales 
 
Varni42 
Varni43 
Varni44 
Varni45 
Varni46 
 
 
 
 
 
 
Amin47 
Huang7 
Varni42 
Varni43 
Varni48 
 
 
Self   
 
 
 
 
 
 
 
 
 
 
Parent  
 
5-18 
 
 
 
 
 
 
 
 
 
 
2-18 
 
 5 (physical health, 
psychosocial health, 
emotional functioning, 
social functioning, school 
functioning) 
 
 
 
 
 
 
 5 (as child version) 
 
23 
 
 
 
 
 
 
 
 
 
 
23 
 
 
1 month 
 
 
 
 
 
 
 
 
 
 
1 month 
4 
 
 
 
 
 
 
 
 
 
 
<5 
Cancer 
Mixed 
Mixed 
Mixed 
Mixed 
 
 
 
 
 
 
Cancer 
Palliative 
Cancer 
Mixed 
Mixed 
Generic USA 
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Measure Study Report Age (y) No. of Domains No. of 
items 
Recall 
period 
Completion 
time  (mins) 
Study 
Population 
Generic/Disease 
Specific 
Country 
of origin 
PedsQLTM Brain 
Tumour Module 
 
 
 
 
 
 
Palmer49 
 
 
 
 
 
 
 
 
 
 
 
 
Self   
 
 
 
 
 
Parent  
5-18 
 
 
 
 
 
2-18 
 
 
 
 
6 (cognitive, pain, 
movement and balance, 
procedural anxiety, 
nausea, worry) 
 
 
6 (as child version) 
 
 
 
 
 
24 
 
 
 
 
 
24 
 
 
 
 
7 days 
 
 
 
 
 
7 days 
 
 
Not 
reported 
 
 
 
 
 
 
 
 
 
 
Brain tumours 
 
 
 
 
 
 
 
 
Disease specific- 
Brain tumour 
 
 
 
 
 
 
 
 
 
 
USA 
 
 
 
PedsQLTMCancer 
Module 
Varni50 Self 
 
 
 
 
 
 
 
Parent 
 
 
 
 
5-18 
 
 
 
 
 
 
 
2-18 
8 (pain, nausea, 
procedural anxiety, 
treatment anxiety, worry, 
cognitive problems, 
perceived physical 
appearance, 
communication) 
 
8 (as child version) 
27 
 
 
 
 
 
 
 
27 
7 days 
 
 
 
 
 
 
 
7 days 
5 
 
 
 
 
 
 
 
5 
Cancer Disease specific - 
cancer 
USA 
PedQLTM3.0 
Cardiac Module 
 
Uzark51 Self 
 
 
 
 
 
Parent 
 
8-18  
 
 
 
 
 
 
8-18  
5 (symptoms, physical 
appearance, treatment 
anxiety, cognitive 
problems, 
communication 
 
 
5 (as child version) 
22 
 
 
 
 
 
 
22 
7 days 
 
 
 
10-15 
 
 
 
 
 
 
10-15 
Cardiac disease Disease specific - 
cardiac disease 
USA 
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Measure Study Report Age (y) No. of Domains No. of 
items 
Recall 
period 
Completion 
time  (mins) 
Study 
Population 
Generic/Disease 
Specific 
Country 
of origin 
PedsQLTMCerebral 
Palsy Module 
Varni52 Self 
 
 
 
 
 
Parent 
 
 
 
 
5-18 
 
 
 
 
 
2-18 
7 (daily activities, school 
activities, movement and 
balance, pain and hurt, 
fatigue, eating, speech 
and communication) 
 
7 (as child version) 
35 
 
 
 
 
 
35 
1 month Not 
reported 
Cerebral palsy Disease specific - 
cerebral palsy 
USA 
PedsQLTM 
Neuromuscular 
module 
Iannaccone53 
Davis54 
Dunaway55 
Self 
 
 
 
 
Parent 
 
 
 
 
5-18 
 
2-18 
3 (about my 
neuromuscular disease, 
communication, family 
resources) 
 
3 
 
25 
 
 
 
 
25 
1 month Not 
reported 
DMDb 
SMAc 
SMA 
Disease specific - 
neuromuscular 
disease 
USA 
Quality of Life in 
Childhood Epilepsy 
Questionnaire 
Sabaz56 
 
 
 
 
 
 
 
 
 
 
Sabaz57 
Parent 4-18 
years 
16 (physical restrictions, 
energy/fatigue, 
depression, anxiety, 
control/helplessness, self-
esteem, 
attention/concentration, 
memory, language, other 
cognitive processes, 
social interactions, 
stigma, behavior, general 
health, quality of life) 
73 4 weeks Not 
reported 
Refractory 
epilepsy 
 
 
 
 
 
 
 
 
 
Epilepsy 
Disease specific - 
epilepsy 
Australia 
 
 
 
 
 
 
 
 
 
 
USA 
version 
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Measure Study Report Age (y) No. of Domains No. of 
items 
Recall 
period 
Completion 
time  (mins) 
Study 
Population 
Generic/Disease 
Specific 
Country 
of origin 
Royal Marsden 
Hospital Paediatric 
Oncology Quality 
of Life 
Questionnaire 
Watson58 Parent 2-19 8 (functional status, 
global health, physical 
symptoms, emotional 
status, social functioning, 
cognitive functioning, 
behavioural problems, 
global quality of life) 
 
78 1 month 15 Cancer Disease specific - 
cancer 
UK 
Sweden 
 
 
amixture of healthy, chronically ill and acutely ill children 
bDuchenne muscular dystrophy 
cSpinal muscular atrophy 
dTwo papers reporting same data 
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Table 4. Methodological quality of included measures 
Study Internal  
Consistency 
Reliability Measurement 
Error 
Content 
Validity 
Structural 
Validity 
Hypothesis 
Testing 
Responsiveness Cross-
cultural 
Validity 
CHQ-PF50 Drotar21 Ferro22 McCullough23 Wake24 
   Good Poor 
    
   Fair Good Good 
   
ConQoL Macran25  Poor  Fair    Excellent     Fair   
CP-QOL Waters26  Poor  Fair    Poor  Fair   
CP-QOL Teen Davis27  Poor  Fair     Poor  Good   
DISABKIDS Petersen28 RavensSieberer19/Schmidt20 Simeoni29 
 Fair Fair Fair 
  Fair Fair 
  Excellent Excellent   
 Fair Fair Fair 
  Fair Fair 
  
DISABKIDS Smiley Chaplin30  Poor    Excellent   
  Poor   
GEOSYP Townshend31  Poor  Poor   Fair   Fair   
HRQOL in Children with 
epilepsy Ronen32   Fair   Fair      Fair   
KIDSCREEN-52 Erhart33        Fair     
MSAS 7-12 Collins34 
 
 Fair     Fair   Fair   
MSAS 10-18 Collins35  Fair  Fair   Fair  Fair  Fair    
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Study Internal  
Consistency 
Reliability Measurement 
Error 
Content 
Validity 
Structural 
Validity 
Hypothesis 
Testing 
Responsiveness Cross-
cultural 
Validity 
PCQL-32 Varni36 Seid37 
 
 Poor Poor    
   Good   Fair Good   
Ped Cardiac QOL 
Inventory Marino38 Marino39 Wray40 
 
  Good    Fair Fair 
   Good    Fair Fair Fair 
  
Ped Oncology QOL Scale Goodwin42   Fair   Poor    Good   Fair   Fair   
PedsQLTMGeneric Core 
Scale (child) Varni42 Varni43 Varni44 Varni45 Varni46 
(parent) Amin47 Huang7 Varni42 Varni43 Varni48 
  Fair Good Poor    Poor Good Fair Good Good 
               
     
              
     Fair   Fair Excellent 
  Fair Good Good  Fair   Poor Fair Good Good 
  
PedsQLTM Brain Tumour 
Module Palmer49   Poor     
    
    
    
  Fair     
    
PedsQLTMCancer Module Varni50  Poor        Fair   
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Study Internal  
Consistency 
Reliability Measurement 
Error 
Content 
Validity 
Structural 
Validity 
Hypothesis 
Testing 
Responsiveness Cross-
cultural 
Validity 
PedsQLTM Cardiac Module Uzark51  Fair        Excellent   
PedsQLTM Cerebral Palsy 
Module Varni52    Poor 
    
      Fair 
  
PedsQLTM Neuromuscular 
Module Davis54 Dunaway55 Iannaconne53 
   Poor  Poor 
   Poor Poor Fair 
    
     Good 
    
   Poor  Fair 
    
 
Quality of Life in 
Childhood Epilepsy 
Questionnaire Sabaz56 Sabaz57 
   Poor Poor 
     Fair 
    Poor Poor 
  
Royal Marsden Ped 
Oncology QOL 
Questionnaire Watson58 
   Poor 
     
     
   Fair 
     Poor 
 
a 2 papers reporting same data            
 35 
Table 5.  Data Synthesis 
 
Questionnaire Internal 
consistency 
Reliability Measurement 
Error 
Content  
Validity 
Structural 
validity 
Hypothesis  
Testing 
Responsiveness Cross-
cultural 
validity 
CHQ-PF50 ±    ±   ? 
ConQOL ? +  +++  ±   
CQOL ? ?  ?  ?   
CP-QOL ? +  ? ? +   
CP-QOL Teen ? + (child) -(parent)   ? -   
DISABKIDS ++ +  +++ ++ ++   
DISABKIDS 
SMILEY 
?   +++  ?   
GEOSYP ? ?  + +    
HRQOL epilespy + +    +   
KIDSCREEN-52     +    
MSAS 7-12 +   +  +   
MSAS 10-18 + ±  + + +   
PCQL-32 ?   ++  ++   
Pediatric cardiac 
quality of life 
inventory 
++ ++  ++  ++   
Pediatric oncology 
quality of life scale 
+ ?  ++ + +   
PedsQLTM Generic +++    ++ ++   
PedsQLTM Brain 
tumour module 
 
?     +   
PedsQLTM 
Cancer module 
 
?      +   
PedsQLTM Cardiac 
module 
+     +++   
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Questionnaire Internal 
consistency Reliability Measurement Error Content  Validity Structural validity Hypothesis  Testing Responsiveness Cross-cultural 
validity 
PedsQLTM 
CP module 
?     +   
PedsQLTM 
Neuromuscular 
module 
? + (child) -(parent)  ++  +   
Quality of Life in 
Childhood 
Epilepsy 
?   +  ?   
Royal Marsden 
Paediatric 
oncology quality 
of life 
questionnaire 
?   +   ?  
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